[HTML][HTML] The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
H Chen, M Yang, Q Wang, F Song, X Li… - Oncoimmunology, 2019 - Taylor & Francis
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …
[引用][C] The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
H Chen, Q Wang, F Song, K Chen, M Yang, X Li - OncoImmunology, 2019 - elibrary.ru
[HTML][HTML] The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
H Chen, M Yang, Q Wang, F Song, X Li… - Oncoimmunology, 2019 - ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …
The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
H Chen, M Yang, Q Wang, F Song, X Li… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …
The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma.
H Chen, M Yang, Q Wang, F Song, X Li, K Chen - Oncoimmunology, 2019 - europepmc.org
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …
The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
H Chen, M Yang, Q Wang, F Song, X Li… - OncoImmunology, 2019 - Taylor & Francis
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …
The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma.
H Chen, M Yang, Q Wang, F Song, X Li, K Chen - Oncoimmunology, 2019 - europepmc.org
Immune checkpoint blockade (ICB) therapy has achieved remarkable clinical benefit in
melanoma. However, our understanding of biomarkers that predict response to ICB …
melanoma. However, our understanding of biomarkers that predict response to ICB …